Electronic Medicinal Product Information (ePI) FHIR Implementation Guide
1.0.0 - trial-use International flag

Electronic Medicinal Product Information (ePI) FHIR Implementation Guide, published by HL7 International - Biomedical Research & Regulation Work Group. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/emedicinal-product-info/ and changes regularly. See the Directory of published versions

Example Bundle: ePI Bundle Type 3 - DrugX Package Insert

Composition status: final
Composition type: Package Leaflet

Narrative Text


B. Package Leaflet

Package leaflet: Information for the user

DrugX 75 mg tablets

acetaminophen

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

  • What DrugX is and what it is used for
  • What you need to know before you take DrugX
  • How to take DrugX
  • Possible side effects
  • How to store DrugX
  • Contents of the pack and other information

1. What DrugX is and what it is used for

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

2. What you need to know before you take DrugX

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

3. How to take DrugX

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

4. Possible side effects

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

5. How to store DrugX

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

6. Contents of the pack and other information

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Product Information

DrugX

PRODUCT: medicinalproduct75

status: Active

Domain: Human use

Combined pharmaceutical dose form:

Legal Status of Supply: Medicinal product subject to medical prescription

Authorisation 1 of 1

Auth id: authorization75mg

Region:

Type: Marketing Authorization

Holder (Organization): acme inc (http://example.org/sid/org#ORG1)

Status: Active (2015-02-07T13:28:17Z)

Package 1 of 1

PRODUCT: EU/1/97/049/001

Description:

Marketing Status: active

Contained Quantity:

  • 75


Package: 28 Blister [PolyVinyl Chloride]

Administrable Product (1 of 1)

Dose form: Tablet

Presentation unit: Tablet

Contents (Manuf. Items):
    3214f286-b8ec-4ef5-bc8d-0aec39d97468

    Dose form: Tablet

    Presentation unit: Tablet

    Manufactured Dose Form: Tablet

    Ingredients:
      745c01bc-936e-45ca-9880-57e97608f43e

      Status: Active

      Role: Active

      Substance: acetaminophen

      09c13040-8fd5-4818-972d-f01d4ee169b6

      Status: Active

      Role: Excipient

      Substance: Silicon dioxide

      a4b7b60c-998f-4f93-89c7-860396af0fe3

      Status: Active

      Role: Excipient

      Substance: Carnauba wax

      fbf58407-83d3-42db-be3d-506b2006d431

      Status: Active

      Role: Excipient

      Substance: Croscarmellose sodium

      1c10b441-6bd3-40b8-b14b-514e7c2f79d0

      Status: Active

      Role: Excipient

      Substance: Hypromellose

      7a3c0b14-2473-4541-9e45-a24d24cceddf

      Status: Active

      Role: Excipient

      Substance: Lactose Monohydrate

      ceba5cd1-321f-4bc3-b203-92d97fcf472e

      Status: Active

      Role: Excipient

      Substance: Macrogol 3000

      eee155e8-e442-491d-9a82-7af3cefac57f

      Status: Active

      Role: Excipient

      Substance: Magnesium stearate

      1cdfb0bc-55f0-43ff-b750-8f3a0d9970bd

      Status: Active

      Role: Excipient

      Substance: Microcrystalline cellulose

      a88891dc-7e9e-4d84-b462-95e53de3b6a6

      Status: Active

      Role: Excipient

      Substance: Titanium Dioxide

Route of administration:
  • Oral route

Clinical Information

Contraindication: Gastrointestinal disorders

Indication: Psoriasis

Interaction: METHOTREXATE

Undesirable Effect: Dysergia

Warning: Symptomatic hypotension, especially after the first dose, may occur in patients.